Why CAR Group, Myer, Neuren, and Yancoal shares are falling today

These shares are having a tough time on hump day. But why?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is running out of steam and fighting hard to stay in positive territory. In afternoon trade, the benchmark index is up slightly to 8,230.9 points.

Four ASX shares that are weighing on the market today are listed below. Here's why they are falling:

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.

Image source: Getty Images

CAR Group Limited (ASX: CAR)

The CAR Group share price is down 1.5% to $37.98. This appears to have been driven by a broker note out of Ord Minnett this morning. According to the note, the broker has downgraded the auto listings company's shares to a hold rating with a $39.00 price target. The broker made the move on valuation grounds after a strong gain on Tuesday drove its shares to a level that is deemed to be fairly valued now.

Myer Holdings Ltd (ASX: MYR)

The Myer share price has continued its slide and is down a further 3% to 81.7 cents. This department store operator's shares are now down almost 30% since this time last week. Investors have been selling Myer's shares following the release of a disappointing trading update. For the 22 weeks ended 28 December, group comparable sales were in line with the prior corresponding period, but total sales were down 0.8% to approximately $1,592 million. And weaker margins led to Myer's EBIT falling approximately 25% to $48 million.

Neuren Pharmaceuticals Ltd (ASX: NEU)

The Neuren Pharmaceuticals share price is down 9% to $10.94. This morning, this pharmaceuticals company announced that its partner Acadia Pharmaceuticals (NASDAQ: ACAD) has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA). This is for trofinetide for the treatment of Rett syndrome in adults and paediatric patients two years of age and older. Acadia anticipates potential approval in the first quarter of 2026. If granted marketing authorisation, trofinetide will be the first and only approved therapy for Rett syndrome in the European Union. The approval timeframe may be longer than some were expecting.

Yancoal Australia Ltd (ASX: YAL)

The Yancoal Australia share price is down 1% to $5.89. This follows news that the coal miner's CEO is stepping down. Yancoal advised that David James Moult will resign after seven years with the company and five years as CEO. Mr Moult decided to retire from full-time employment to devote more time to his other business engagements. His employment will end on 14 July 2025, but active duties have ceased immediately.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Car Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

Bored man sitting at his desk with his laptop.
Share Fallers

Why Appen, Catalyst Metals, South32, and Woolworths shares are sinking today

These shares are having a poor session on Thursday. What's going on?

Read more »

A man in a business suit hangs in mid air facing the floor as he plunges to the ground.
Share Fallers

Why Appen shares just crashed 28% despite a return to growth

Appen shares tank 28% as the quarterly update rattles investors.

Read more »

An older man wearing glasses and a pink shirt sits back on his lounge with his hands behind his head and blowing air out of his cheeks.
Share Fallers

Why Catalyst Metals, G8 Education, Meteoric Resources, and Westgold shares are falling today

These shares are having a tough time on hump day. But why?

Read more »

ASX share investor sitting with a laptop on a desk, pondering something.
Share Fallers

CSL shares crash to a 9-year low. Is it time to sell off my shares?

What's next for the beaten-down ASX biotech stock?

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Beach Energy, Domino's, Origin Energy, and Pantoro Gold shares are dropping today

Why are these shares under pressure? Let's find out.

Read more »

Frustrated and shocked business woman reading bad news online from phone.
Gold

Why is this $1.5 billion ASX 200 gold stock tumbling 8% today?

Still up 31% in a year, this ASX 200 gold stock is getting hammered today. But why?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Cochlear, Karoon Energy, Origin Energy, and WiseTech shares are falling today

These shares are starting the week in the red. Let's find out why.

Read more »

An arrow crashes through the ground as a businessman watches on.
Share Fallers

After falling 43% in a week, are Cochlear shares now a buy?

Is this drop a warning sign?

Read more »